Auris Medical to present at the Leerink Global Healthcare Conference
04 févr. 2015 06h00 HE
|
Auris Medical AG
Zug, Switzerland, February 4, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage biopharmaceutical company dedicated to developing therapeutics that address important unmet medical...
Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial
14 janv. 2015 05h01 HE
|
Auris Medical AG
Zug, Switzerland, January 14, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it has enrolled the first 150 patients with post-acute tinnitus in Stratum B of the Company's...
Auris Medical Q3 2014 Earnings Release
03 déc. 2014 07h00 HE
|
Auris Medical AG
Auris Medical Holding AG Reports Third Quarter 2014 Financial Results and Provides Business Update Zug, Switzerland, December 3, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today provided an...
Auris Medical to Announce Third Quarter 2014 Financial Results and Host Conference Call on Wednesday, December 3, 2014
01 déc. 2014 04h46 HE
|
Auris Medical AG
Zug, Switzerland, December 1, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it will release its financial results for the third quarter ended September 30, 2014, on...
Auris Medical Holding AG Reports Second Quarter 2014 Financial Results and Provides Business Update
15 sept. 2014 07h30 HE
|
Auris Medical AG
Zug, Switzerland, September 15, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the second quarter ended June...
Auris Medical to Announce Second Quarter 2014 Financial Results and Host Conference Call on Monday, September 15, 2014
08 sept. 2014 08h30 HE
|
Auris Medical AG
Zug, Switzerland, September 8, 2014 - Auris Medical Holding AG (NASDAQ: EARS) today announced that it will release its financial results for the second quarter ended June 30, 2014, on Monday,...
Auris Medical Holding AG Announces Exercise of IPO Over-Allotment Option
19 août 2014 11h09 HE
|
Auris Medical AG
Zug, Switzerland, August 19, 2014 - Auris Medical Holding AG (NASDAQ: EARS) announced today that the underwriters of its initial public offering have exercised their over-allotment option to...
Auris Medical Holding AG Announces Closing of Initial Public Offering
11 août 2014 11h08 HE
|
Auris Medical AG
Zug, Switzerland, August 11, 2014 - Auris Medical Holding AG announced today the closing of its previously announced initial public offering of 9,400,000 of its ordinary shares at an initial public...
Auris Medical Holding AG Announces Pricing of Initial Public Offering
05 août 2014 18h53 HE
|
Auris Medical AG
Zug, Switzerland, August 5, 2014 - Auris Medical Holding AG announced today the pricing of its initial public offering of 9,400,000 of its common shares at an initial public offering price of USD...
Auris Medical Holding AG Commences Proposed Initial Public Offering of Common Shares
21 juil. 2014 07h00 HE
|
Auris Medical AG
Zug, Switzerland, July 21, 2014 - Auris Medical Holding AG announced today that it has commenced the underwritten initial public offering of 6,900,000 of its common shares (Offering) pursuant to a...